Capstone Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
6,800
+3,700
+119% +$797K ﹤0.01% 734
2025
Q4
$637K Sell
3,100
-2,000
-39% -$376K ﹤0.01% 1051
2025
Q3
$800K Buy
5,100
+1,300
+34% +$201K ﹤0.01% 1119
2025
Q2
$638K Sell
3,800
-3,100
-45% -$460K ﹤0.01% 1033
2025
Q1
$951K Sell
6,900
-7,500
-52% -$956K ﹤0.01% 898
2024
Q4
$1.7M Buy
14,400
+5,300
+58% +$619K ﹤0.01% 893
2024
Q3
$1.01M Buy
9,100
+300
+3% +$31.4K ﹤0.01% 961
2024
Q2
$865K Buy
8,800
+800
+10% +$81.5K ﹤0.01% 1051
2024
Q1
$895K Sell
8,000
-1,600
-17% -$173K ﹤0.01% 1214
2023
Q4
$968K Buy
9,600
+1,100
+13% +$109K ﹤0.01% 1062
2023
Q3
$738K Buy
8,500
+3,100
+57% +$280K ﹤0.01% 1116
2023
Q2
$511K Buy
5,400
+300
+6% +$25.3K ﹤0.01% 1152
2023
Q1
$385K Buy
+5,100
New +$385K ﹤0.01% 1089
2022
Q4
Sell
-4,100
Closed -$273K 1530
2022
Q3
$273K Buy
4,100
+400
+11% +$25.4K ﹤0.01% 1405
2022
Q2
$193K Sell
3,700
-27,100
-88% -$1.54M ﹤0.01% 1424
2022
Q1
$1.75M Sell
30,800
-5,200
-14% -$278K ﹤0.01% 1124
2021
Q4
$1.85M Buy
36,000
+5,400
+18% +$265K ﹤0.01% 1139
2021
Q3
$1.51M Sell
30,600
-5,900
-16% -$320K ﹤0.01% 1288
2021
Q2
$2.08M Buy
36,500
+8,900
+32% +$520K ﹤0.01% 1010
2021
Q1
$1.68M Buy
27,600
+16,400
+146% +$905K ﹤0.01% 984
2020
Q4
$600K Sell
11,200
-7,500
-40% -$389K ﹤0.01% 1214
2020
Q3
$878K Buy
18,700
+6,300
+51% +$323K ﹤0.01% 1045
2020
Q2
$647K Buy
12,400
+5,200
+72% +$268K ﹤0.01% 1025
2020
Q1
$345K Sell
7,200
-33,500
-82% -$1.74M 0.01% 950
2019
Q4
$2.06M Buy
40,700
+17,900
+79% +$925K 0.01% 822
2019
Q3
$1.08M Sell
22,800
-16,000
-41% -$730K 0.01% 918
2019
Q2
$1.83M Buy
38,800
+25,900
+201% +$1.19M 0.01% 768
2019
Q1
$621K Buy
12,900
+7,500
+139% +$376K 0.01% 949
2018
Q4
$241K Buy
5,400
+2,600
+93% +$136K ﹤0.01% 989
2018
Q3
$151K Buy
+2,800
New +$143K ﹤0.01% 1066

Other funds holding CAH

Capstone Investment Advisors's CAH Position: Q1 2026 in Review

Capstone Investment Advisors increased its Cardinal Health (CAH) stake by 12% in Q1 2026, buying an estimated $67.8K and bringing the position to 2,923 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Capstone Investment Advisors first reported a position in CAH in Q3 2015 and has held it in 19 quarters since. The position peaked at $3.5M in Q3 2021. 1,429 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Capstone Investment Advisors held 2,923 shares of Cardinal Health worth $618K as of Q1 2026.
  • Capstone Investment Advisors bought 315 Cardinal Health shares in Q1 2026, an estimated $67.8K.
  • Cardinal Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1044 holding.
  • Capstone Investment Advisors first reported a position in Cardinal Health in Q3 2015 and has held it in 19 quarters since.
  • Capstone Investment Advisors's Cardinal Health position peaked at $3.5M in Q3 2021.
  • 1,429 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.